Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Jul 2026, 02:08
Evidence Synthesis
CLEDUCATE's 26.05% gross margin accelerated to, up from -8.02%.
The company's .02% marginal operating leverage decelerated, down from .72%. CLEDUCATE's to . The .07 INR close price accelerated to, up from .01 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 26.05 % | -8.02 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -8.02 % | -4.72 | ▼ |
| REVENUE_GROWTH_YOY | 24 % | — | - |
| PRICE_CHANGE_PERCENT | 0.103 % | — | - |
| DAILY_VOLUME | 23,945 shares | 44,875 | ▼ |
| CLOSE_PRICE | 58.07 INR | 58.01 | ▲ |